Novartis AG Goodwill and Intangible Assets 2010-2024 | NVS

Novartis AG goodwill and intangible assets for the quarter ending June 30, 2024 were $53.009B, a 7.85% decline year-over-year.

  • Novartis AG goodwill and intangible assets for 2023 were $50.22B, a 17.6% decline from 2022.
  • Novartis AG goodwill and intangible assets for 2022 were $60.945B, a 4.44% decline from 2021.
  • Novartis AG goodwill and intangible assets for 2021 were $63.777B, a 4.54% decline from 2020.

Novartis AG Goodwill and Intangible Assets 2010-2024 | NVS

  • Novartis AG goodwill and intangible assets for 2023 were $50.22B, a 17.6% decline from 2022.
  • Novartis AG goodwill and intangible assets for 2022 were $60.945B, a 4.44% decline from 2021.
  • Novartis AG goodwill and intangible assets for 2021 were $63.777B, a 4.54% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M